Nathaniel Katz

Biography

 Nathaniel Katz, M.D., M.S., is internationally recognized for his expertise in pain management, analgesic clinical trials and investigations focusing on opioids and risk management. As president and founder of Analgesic Solutions, Nathaniel established the company with the mission of modernizing the design and conduct of pain clinical trials to advance the scientific quality of pain clinical research and to empower effective treatments for patients. Prior to founding Analgesic Solutions, Nathaniel was a staff neurologist in the Pain Management Center of Brigham & Women’s hospital where he also founded the Pain Trials Center, a clinical analgesic research unit. He also founded the Pain & Symptom Management Program at Dana-Farber Cancer Institute. In addition to having served on numerous scientific advisory boards, Nathaniel has served as chairman to the Advisory Committee of Anesthesia, Critical Care and Addition Products Division of the FDA, as well as to the National Initiative on Pain Control. He is currently an adjunct assistant professor of Anesthesia at Tufts University School of Medicine and an active member of IMMPACT (Initiative on Methods, Measurements, and Pain Assessment in Clinical Trials). Nathaniel completed his neurology residency at Tufts New England Medical Center and later entered a pain management fellowship in the Department of Anesthesia at Brigham & Women’s Hospital. He received his medical degree from the Medical College of Pennsylvania and his M.S. in biostatistics from Columbia University.

Research Interest

 His research interests are in the field of Anesthesiology- pain management and neurology